Trials / Unknown
UnknownNCT05352113
Intradermal Needle Therapy for Major Depressive Disorder
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University · Academic / Other
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Major depressive disorder (MDD) is a common mental disorder that affects patients' physical health and quality of life. Although traditional acupuncture therapy has certain advantages in improving MDD, there are still some limitations, such as being time-consuming and some people having a fear of acupuncture. Therefore, intradermal needle therapy will be chosen in the treatment of MDD in this study, which is more convenient, shallow needling, and gentle than traditional acupuncture therapy. The study is designed to investigate the therapeutic effect and safety of intradermal needles for MDD.
Detailed description
A total of 120 participants with MDD who meet the inclusion criteria will be included in the study. Participants will be randomly divided into the SSRIs + acupuncture group, acupuncture + placebo group, and SSRIs + sham acupuncture group. This study will evaluate the efficacy and safety of the intradermal needle for MDD and investigate whether the intradermal needle reduces side effects and increases the efficacy of selective serotonin reuptake inhibitors (SSRIs) antidepressants for MDD. Furthermore, the study will demonstrate whether the intradermal needle has a synergistic effect with SSRIs on the treatment of MDD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SSRIs | SSRIs antidepressants will be used and the oral dose will be determined by the clinical specialist. Once-daily for 6 weeks. |
| PROCEDURE | acupuncture | This study will use the intradermal needle as an acupuncture intervention. Acupoints related to MDD will be stimulated. According to the position of the acupoints, choose a needle of φ0.20\*1.5m or φ0.20\*1.2mm. Press the needle to insert the acupoint vertically and retain it in the skin. After the intervention, the needle will be retained for 72 hours with a day of rest after removal. During needle retention, participants will be instructed to press the acupoints 3-4 times a day for about 1 minute each time, with the amount of stimulation as much as the patient can tolerate, at an interval of about 4 hours. A total of 10 treatment sessions will be performed for 6 weeks. |
| PROCEDURE | sham acupuncture | Sham acupuncture will use the same size, color, and material as the verum intradermal needle with a thin silicone pad in the middle instead of the needle body. The sham acupuncture will be needled on the points 1cm lateral to MDD-related acupoints. After the intervention, the needle will be retained for 72 hours with a day of rest after removal. A total of 10 sessions will be performed for 6 weeks. |
| DRUG | placebo | Oral placebo mimicking SSRIs antidepressants. Once-daily for 6 weeks. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2025-05-01
- Completion
- 2025-12-30
- First posted
- 2022-04-28
- Last updated
- 2022-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05352113. Inclusion in this directory is not an endorsement.